open access

Vol 68, No 5-6 (2018)
Review paper
Published online: 2019-05-07
Get Citation

Molecular markers used in breast cancer diagnosis — current practice and future perspectives

Anna Walaszczyk, Dorota Gabryś
DOI: 10.5603/2018.0041
·
Nowotwory. Journal of Oncology 2018;68(5-6):259-267.

open access

Vol 68, No 5-6 (2018)
Review article
Published online: 2019-05-07

Abstract

Breast cancer is the most frequently diagnosed cancer among women and a leading cause of cancer-related death. Despite many available diagnostic tools and techniques, tumor heterogeneity and molecular diversity of breast cancer tumors require new biomarkers in clinical practice. A potential diagnostic test can be built based on few biomarkers. Those biomarkers may not be specific and sensitive enough to be a single diagnostic tool, but might be useful as a set of biomarkers e.g. CEA, CA15-3, MammaPrint®, HER2 and BRCA1, 2. The second group of potential biomarkers are microRNAs. Changes in miRNA and altered genes expression may contribute to the development of breast cancer and metastases. Integration of proteomics, genomics, and metabolomics data is necessary to discover a new panel of biomarkers.

Abstract

Breast cancer is the most frequently diagnosed cancer among women and a leading cause of cancer-related death. Despite many available diagnostic tools and techniques, tumor heterogeneity and molecular diversity of breast cancer tumors require new biomarkers in clinical practice. A potential diagnostic test can be built based on few biomarkers. Those biomarkers may not be specific and sensitive enough to be a single diagnostic tool, but might be useful as a set of biomarkers e.g. CEA, CA15-3, MammaPrint®, HER2 and BRCA1, 2. The second group of potential biomarkers are microRNAs. Changes in miRNA and altered genes expression may contribute to the development of breast cancer and metastases. Integration of proteomics, genomics, and metabolomics data is necessary to discover a new panel of biomarkers.

Get Citation

Keywords

breast cancer; biomarker; molecular biomarker; diagnostics; early detection

About this article
Title

Molecular markers used in breast cancer diagnosis — current practice and future perspectives

Journal

Nowotwory. Journal of Oncology

Issue

Vol 68, No 5-6 (2018)

Article type

Review paper

Pages

259-267

Published online

2019-05-07

Page views

573

Article views/downloads

1674

DOI

10.5603/2018.0041

Bibliographic record

Nowotwory. Journal of Oncology 2018;68(5-6):259-267.

Keywords

breast cancer
biomarker
molecular biomarker
diagnostics
early detection

Authors

Anna Walaszczyk
Dorota Gabryś

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl